US Broker Ratings

UFP Technologies, Inc. (UFPT) Stock Analysis: Potential Upside of Nearly 60% Captivates Investors

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector specializing in medical devices, is generating significant buzz among investors with its impressive potential upside of nearly 60%..

Certara, Inc. (CERT) Stock Analysis: Unlocking a 41% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT), a leader in health information services, is presenting a potentially lucrative opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of $1.03..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring Growth Potential with 10.84% Upside

Twist Bioscience Corporation (NASDAQ: TWST), headquartered in South San Francisco, California, is a prominent player in the healthcare sector, specializing in the diagnostics and research industry. With a market capitalization..

Agios Pharmaceuticals (AGIO) Stock Analysis: Evaluating the 38% Upside Potential in Biotechnology

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a pioneering biopharmaceutical company, stands at the forefront of cellular metabolism therapy. With a market capitalization of $1.69 billion, this Massachusetts-based biotech firm has garnered..

Warby Parker Inc. (WRBY) Stock Analysis: Exploring a 25% Upside Potential

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector’s niche of medical instruments and supplies, has carved out a distinct identity with its innovative approach to eyewear..

Crinetics Pharmaceuticals, Inc. (CRNX): Investor Outlook Highlights 123.98% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is a formidable player in the biotechnology sector, dedicated to pioneering novel therapeutics for rare endocrine diseases and endocrine-related tumors. With a market capitalization of..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Look at Its 40% Upside Potential

Investors with a keen interest in the biotechnology sector should pay close attention to Centessa Pharmaceuticals plc (NASDAQ: CNTA). This clinical-stage pharmaceutical company, headquartered in Altrincham, United Kingdom, is making..

Select Medical Holdings Corpora (SEM)

⚠️ No article content returned.

..

Metsera, Inc. (MTSR) Stock Analysis: Navigating the Biotech Waves Post-Pfizer Acquisition

Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biotechnology firm based in New York, is creating ripples in the healthcare sector with its innovative approaches to combat obesity and related diseases. Now..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 44% Upside Potential in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector focusing on diagnostics and research, presents a compelling opportunity for investors looking to tap into the burgeoning market for..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 37.66% Potential Upside in the Healthcare Sector

Ardent Health, Inc. (NASDAQ: ARDT) has emerged as a notable player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $1.32 billion, this..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: A Closer Look at Its Valuation and Growth Potential

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands as a prominent player in the U.S. healthcare sector, specializing in providing a range of behavioral healthcare services. With a market capitalization of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 45.63% Potential Upside

For investors keen on the healthcare sector, Alignment Healthcare, Inc. (NASDAQ: ALHC) offers an intriguing opportunity with a significant potential upside of 45.63%. This California-based company operates a consumer-centric healthcare..

Immunovant, Inc. (IMVT) Stock Analysis: Unpacking a 64.5% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector should take a closer look at Immunovant, Inc. (NASDAQ: IMVT), a promising player in the burgeoning field of monoclonal antibodies for..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Gem with a 27.89% Potential Upside

Belite Bio, Inc (BLTE), a dynamic player in the biotechnology sector, stands out as a promising investment opportunity, particularly for those interested in the cutting-edge field of retinal degenerative diseases...

NovoCure Limited (NVCR) Stock Analysis: Exploring a Potential 109% Upside with Innovative Cancer Treatment Solutions

NovoCure Limited (NASDAQ: NVCR), a pioneering force in the medical device sector, is captivating investor attention with its innovative tumor treating fields (TTFields) technology. This Switzerland-based company, with a market..

Addus HomeCare Corporation (ADUS) Stock Analysis: Unveiling a 38.92% Potential Upside Opportunity

Investors seeking opportunities in the healthcare sector should take a closer look at Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the medical care facilities industry. With a market..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Discover a 52.45% Potential Upside with Robust Revenue Growth

LifeStance Health Group, Inc. (NASDAQ: LFST) is setting a distinct tone in the healthcare sector, particularly within the medical care facilities industry, with its innovative approach to mental health services...

LivaNova PLC (LIVN) Stock Analysis: Potential 30% Upside Amid Strong Buy Ratings

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its robust 30.08% potential upside, as indicated by..

Privia Health Group, Inc. (PRVA) Investor Outlook: A Promising 45% Upside with Strong Buy Ratings

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector, particularly within the health information services industry. With a market capitalization of $2.72 billion, this Arlington, Virginia-based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds